WILMINGTON, Del., April 02, 2018 -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of CommerceHub, Inc. (“CommerceHub” or the “Company”) relating to the sale of the Company to affiliates of private equity firms GTCR and Sycamore Partners. On March 6, 2018, the parties announced the signing of a definitive merger agreement pursuant to which GTCR and Sycamore Partners will acquire CommerceHub in a merger worth $1.1 billion. As a result of the buyout, CommerceHub shareholders are only anticipated to receive $22.75 per share in cash in exchange for each share of CommerceHub.
Andrews & Springer’s investigation so far has revealed that the consideration CommerceHub shareholders are expected to receive is inadequate. The $22.75 per share consideration is also below CommerceHub’s December 18, 2017 closing price of $23.43 per share. In addition, while the Company claims that shareholders will receive a premium for their shares, the deal consideration is significantly less than the $28.00 and $27.00 price targets set by analysts at Northland Capital Markets and Dougherty & Company LLC on March 1, 2018, just five (5) days before the merger was announced. Since the announcement of the merger, an analyst at William Blair has even stated that “At first glance, the acquisition price is below what we would have expected CommerceHub to sell for. Series A shares have traded above the $22.75 level a couple of times over the past six months. . . .” according to a report issued on March 6, 2018.
If you own shares of CommerceHub and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/commercehub-class-action-investigation/ or contact Craig J. Springer, Esq. at [email protected], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.
Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute. For more information please visit our website at www.andrewsspringer.com. This notice may constitute Attorney Advertising.
Contact: Craig J. Springer, Esq.
[email protected]
Toll Free: 1-800-423-6013


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



